Tuberculosos pandemic and dissemination of drug resistant strains: a challenge for Bulgaria
2011

Drug-Resistant Tuberculosis in Bulgaria

publication

Author Information

Author(s): Valcheva Violeta, Mokrousov Igor, Narvskaya Olga, Rastogi Nalin, Markova Nadya

Primary Institution: The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences

Hypothesis

The study evaluates fast molecular methods to detect drug-resistant tuberculosis and the distribution of resistant properties in different clonal lineages of M. tuberculosis in Bulgaria versus its neighbors.

Conclusion

The M. tuberculosis population in Bulgaria has several specific lineages, and certain mutations can help quickly identify drug-resistant strains.

Supporting Evidence

  • The rate of multidrug-resistant tuberculosis among newly diagnosed patients in Bulgaria is estimated to be 10.7%.
  • Mutations in rpoB531 were found in 65% of RIF-resistant strains.
  • Mutations in katG315 and inhA -15 were detected in 50% of INH-resistant strains.
  • 63% of EMB-resistant strains had the embB306 mutation.

Takeaway

This study looks at how to find drug-resistant tuberculosis quickly in Bulgaria, which has its own unique strains.

Methodology

Different typing methods were used to study drug-resistant and susceptible M. tuberculosis strains from newly diagnosed patients.

Limitations

The results for INH resistance are complex and more genes should be studied.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication